3 ms·
Mismatch of incentives I think. Insurance companies and drug companies may not be interested in evidence-based selection. I suspect they would prefer biased res
by glitchc 5y ago
Mismatch of incentives I think. Insurance companies and drug companies may not be interested in evidence-based selection. I suspect they would prefer biased results i.e. insurance would want the cheapest and deug companies would want the most revenue generating. Neither may be the optimal choice for the patient.
- pandemicsoul 5y agoYeah, but if his tool showed – hypothetically – that in 75% of cases the generic (or just the cheaper medication) was just as good or better, that seems like it would have been a slam dunk?